Znaor A, Skakkebæk NE, Rajpert-De Meyts E, et al. - Given testicular cancer remains the most prevalent cancer among young men of European ancestry, with approximately one-third of all cases happening in Europe, and in recent years, stabilization has been observed in the historically growing trends in some high-incidence populations, therefore, researchers analyzed recent trends as well as predicted the future testicular cancer incidence burden across Europe. According to them, there will be an increment in the incidence rates of testicular cancer in 21 out of 28 countries from 2010 to 2035, with trends attenuating in the high-incidence populations of Denmark, Norway, Switzerland and Austria. Although the number of cases would be expected to decline as a result of population ageing, this demographic influence is outweighed by the rising risk, resulting in an overall surge in the number of cases by 2035 in Europe, and according to the region. Overall, a continuous rise in the burden of testicular cancer incidence in Europe is predicted, especially in historically lower-risk countries. By experts' prediction, Eastern Europe, where survival is lower, is going to encounter the largest increase in the number of testicular cancer patients. This strengthens the requirement to ensure the provision of effective treatment across Europe.